Impact of Minimal Residual Negativity using Next Generation Flow Cytometry on Outcomes in Light Chain Amyloidosis

We evaluated bone marrow minimal residual disease (MRD) negativity in 44 patients with light chain (AL) amyloidosis using next generation flow cytometry (sensitivity ≥ 1× 10(−5); median events analyzed: 8.7 million, range: 4.8 to 9.7 million). All patients underwent MRD testing in two years from sta...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Am J Hematol
Main Authors: Sidana, Surbhi, Muchtar, Eli, Sidiqi, M.Hasib, Jevremovic, Dragan, Dispenzieri, Angela, Gonsalves, Wilson, Buadi, Francis, Lacy, Martha Q., Hayman, Suzanne R., Kourelis, Taxiarchis, Kapoor, Prashant, Go, Ronald S., Warsame, Rahma, Leung, Nelson, Rajkumar, S.Vincent, Kyle, Robert A., Gertz, Morie A., Kumar, Shaji K.
Format: Artigo
Sprog:Inglês
Udgivet: 2020
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8019396/
https://ncbi.nlm.nih.gov/pubmed/32010993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.25746
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker